✦ LIBER ✦

Benefit-Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation

✍ Scribed by Stefan H. Hohnloser

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiarrhythmic drug therapy of atrial fi

✍ VerNooy, Robert A; Mounsey, J.Paul 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Current strategies of antiarrhythmic dru

✍ Takashi Komatsu 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 818 KB

798-5 Risk of Initiating Antiarrhythmic

✍ Maisel, William H.; Lee, Thomas H.; Antman, Elliott M.; Reimold, Sharon C.; Frie 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Novel Antiarrhythmic Drugs for the Treat

✍ Nakaya, Haruaki 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 76 KB

Risk-benefit profiles of antiarrhythmic

✍ Ronald W.F. Campbell; Kishore Nimkhedkar 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Non-Antiarrhythmic Drugs in Atrial Fibri

✍ JAMES A. LALLY; ERIC M. GNALL; JONATHAN SELTZER; PETER R. KOWEY 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB